EdgarLookup

ENDRA Life Sciences Inc. — 8-K Filings

107 8-K filings on record

This page lists all 8-K filings submitted to the SEC by ENDRA Life Sciences Inc. (NDRA), sorted by most recent first. Each row links to the full filing on EdgarLookup. ENDRA Life Sciences Inc. has filed 107 8-K documents with the SEC since 2016. To view all SEC filings by ENDRA Life Sciences Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 25-NSE 3 3/A 4 4/A 424B1 424B3 424B4 424B5 424B7 8-A12B 8-A12B/A 8-A12G 8-K 8-K/A ARS CERTNAS CERTNYS CORRESP D DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT NT 10-Q POS AM PRE 14A S-1 S-1/A S-1MEF S-3 S-3/A S-8 SC 13G SC 13G/A SCHEDULE 13D SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
8-K FORM 8-K 0001654954-22-000322 Jan 7, 2022 Jan 5, 2022
8-K CURRENT REPORT 0001654954-21-012220 Nov 15, 2021
8-K CURRENT REPORT 0001654954-21-008841 Aug 12, 2021
8-K CURRENT REPORT 0001654954-21-007094 Jun 21, 2021
8-K CURRENT REPORT 0001654954-21-006899 Jun 15, 2021 Jun 9, 2021
8-K CURRENT REPORT 0001654954-21-006684 Jun 8, 2021
8-K CURRENT REPORT 0001654954-21-005871 May 17, 2021
8-K CURRENT REPORT 0001654954-21-004654 Apr 27, 2021
8-K CURRENT REPORT 0001654954-21-003292 Mar 25, 2021
8-K CURRENT REPORT 0001654954-21-002404 Mar 5, 2021
8-K FORM 8-K 0001654954-21-001916 Feb 19, 2021
8-K CURRENT REPORT 0001654954-21-001109 Feb 3, 2021 Feb 2, 2021
8-K CURRENT REPORT 0001654954-21-000306 Jan 11, 2021
8-K CURRENT REPORT 0001654954-20-014026 Dec 30, 2020 Dec 28, 2020
8-K CURRENT REPORT 0001654954-20-013801 Dec 21, 2020 Dec 16, 2020
8-K CURRENT REPORT 0001654954-20-013753 Dec 18, 2020 Dec 15, 2020
8-K CURRENT REPORT 0001654954-20-013567 Dec 15, 2020
8-K CURRENT REPORT 0001654954-20-013538 Dec 14, 2020
8-K CURRENT REPORT 0001654954-20-012472 Nov 16, 2020
8-K CURRENT REPORT 0001654954-20-010481 Sep 25, 2020
8-K CURRENT REPORT 0001654954-20-010426 Sep 24, 2020 Sep 18, 2020
8-K CURRENT REPORT 0001654954-20-009764 Sep 2, 2020 Sep 1, 2020
8-K CURRENT REPORT 0001654954-20-009423 Aug 21, 2020 Aug 19, 2020
8-K CURRENT REPORT 0001654954-20-009242 Aug 17, 2020
8-K CURRENT REPORT 0001654954-20-007924 Jul 22, 2020
8-K CURRENT REPORT 0001654954-20-006789 Jun 18, 2020 Jun 16, 2020
8-K FORM 8-K 0001654954-20-006146 Jun 1, 2020
8-K CURRENT REPORT 0001654954-20-005473 May 14, 2020
8-K CURRENT REPORT 0001654954-20-004473 Apr 27, 2020 Apr 21, 2020
8-K CURRENT REPORT 0001654954-20-003997 Apr 13, 2020 Apr 9, 2020
8-K CURRENT REPORT 0001654954-20-003787 Apr 3, 2020 Mar 31, 2020
8-K CURRENT REPORT 0001654954-20-003393 Mar 27, 2020
8-K CURRENT REPORT 0001654954-20-003330 Mar 26, 2020
8-K CURRENT REPORT 0001654954-20-002407 Mar 10, 2020
8-K CURRENT REPORT 0001654954-20-000453 Jan 15, 2020 Jan 13, 2020
8-K CURRENT REPORT 0001654954-19-014269 Dec 27, 2019
8-K CURRENT REPORT 0001654954-19-014235 Dec 26, 2019 Dec 19, 2019
8-K CURRENT REPORT 0001654954-19-014072 Dec 19, 2019
8-K CURRENT REPORT 0001654954-19-013822 Dec 11, 2019 Dec 5, 2019
8-K CURRENT REPORT 0001654954-19-012843 Nov 13, 2019
8-K CURRENT REPORT 0001654954-19-009726 Aug 16, 2019 Aug 14, 2019
8-K CURRENT REPORT 0001654954-19-008564 Jul 29, 2019 Jul 26, 2019
8-K CURRENT REPORT 0001654954-19-006338 May 20, 2019 May 16, 2019
8-K CURRENT REPORT 0001654954-19-002547 Mar 11, 2019
8-K ENDRA LIFE SCIENCES INC. 0001654954-18-012539 Nov 13, 2018 Nov 8, 2018
8-K CURRENT REPORT 0001654954-18-011232 Oct 16, 2018 Oct 10, 2018
8-K CURRENT REPORT 0001654954-18-009335 Aug 17, 2018 Aug 16, 2018
8-K CURRENT REPORT 0001654954-18-007790 Jul 18, 2018
8-K CURRENT REPORT 0001654954-18-007217 Jul 2, 2018 Jun 28, 2018
8-K CURRENT REPORT 0001654954-18-006687 Jun 15, 2018 Jun 12, 2018